Understanding Clinical Trials
- 0About this program
- 1What is a clinical trial?
- 2Can I take part in a clinical trial?
- 3What medicine would I receive as part of a clinical trial?
- 4What do I have to do in a clinical trial?
- 5How safe is a clinical trial?
- 6Do I have to pay to take part?
- 7Why would I take part in a clinical trial?
- 8How do I find a clinical trial?
- 0About this program
- 1What is a clinical trial?
- 2Can I take part in a clinical trial?
- 3What medicine would I receive as part of a clinical trial?
- 4What do I have to do in a clinical trial?
- 5How safe is a clinical trial?
- 6Do I have to pay to take part?
- 7Why would I take part in a clinical trial?
- 8How do I find a clinical trial?
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.
What medicine would I receive as part of a clinical trial?
Myth: The placebo is always the alternative to the investigational medication
A placebo is a sugar pill that does not cause harm or good. In many trials testing an investigational medication, a proportion of the people recruited will receive a placebo without knowing if they are receiving the investigational medication or the placebo.
When you may not get a placebo
The decision about whether to use a placebo in a clinical trial is based on how serious the illness is, whether an existing treatment is available, and other considerations that ensure a high standard of ethics.
For example:
- In trials where a treatment is already available for the disease or condition, or in the case of serious illness, the available treatment (or standard of care) is usually used instead of a placebo.
- Where there are no current treatments, trials may have one group getting the new treatment with another group getting a placebo.
The group of patients given the placebo or standard of care are called the control group, as they are the patients receiving the current standard and what the new drug will be compared against.
Patient perspectives
After enrolling in a trial for a drug that didn’t work, Burns remains positive:
“If the drug had worked, it would have helped me and other people. Less than one percent of people with Parkinson’s disease participate in clinical trials, but if nobody does it, we’ll never succeed.”
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.